Its ability to modulate key inflammatory pathways and target critical proteins such as CXCL8 positions cinnamaldehyde as a promising candidate for personalized treatment strategies aimed at mitigating COPD symptoms and progression. This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.